India’s Bioeconomy 2025 में $195 bn तक बढ़ी – 17‑18% YoY Growth, BioE3 Policy & RDI Fund बायोटेक को तेज़ करता है

<h2>India’s Bioeconomy Expands Rapidly – Key Policy Pushes Highlighted</h2> <p>Union Minister of State (Independent Charge) for Science &amp; Technology, <strong>Dr Jitendra Singh</strong>, announced that the nation’s <span class="key-term" data-definition="Bioeconomy – economic activities that use biological resources, processes and principles to produce goods and services; a focus area for GS3 (Economy) and GS1 (Science & Technology) in UPSC.">Bioeconomy</span> has risen from about <strong>USD 10 billion in 2014</strong> to **USD 195 billion in 2025**, registering a **17‑18% annual growth** in the last year. The sector now contributes **≈4.8% to India’s GDP** and positions the country as a global biotechnology hub.</p> <h3>Key Developments</h3> <ul> <li>India aims for a <strong>USD 300 billion bioeconomy by 2030</strong>, driven by a strong base of scientists, entrepreneurs and more than <span class="key-term" data-definition="Biotech startups – young enterprises focused on biotechnology innovations; they are crucial for job creation and technology transfer (GS3).">11,800 biotech startups</span>.</li> <li>Launch of the <span class="key-term" data-definition="BioE3 Policy – ‘Biotechnology for Economy, Environment and Employment’; a policy framework to promote bio‑based industries and sustainable manufacturing (GS3).">BioE3 Policy</span>, targeting precision biotherapeutics, smart proteins, climate‑resilient agriculture, bio‑based chemicals and carbon‑capture technologies.</li> <li>Establishment of shared infrastructure such as <em>bio‑foundries, Bio‑AI hubs and advanced biomanufacturing platforms</em> under BIRAC’s guidance.</li> <li>Announcement of a <span class="key-term" data-definition="RDI Fund – Research, Development and Innovation Fund aimed at channeling long‑term investment into biotech scale‑up projects (GS3).">₹1 lakh‑crore RDI Fund</span>, with <strong>BIRAC</strong> as the nodal agency for funding scale‑up and technology translation.</li> </ul> <h3>Important Facts</h3> <ul> <li>Annual growth rate of **17‑18%** in 2025, up from **USD 165 billion** in 2024.</li> <li>Compound Annual Growth Rate (<span class="key-term" data-definition="CAGR – Compound Annual Growth Rate; a measure of the mean annual growth rate of an investment over a specified period (GS3).">CAGR</span>) of **≈18%** since 2020.</li> <li>India’s bioeconomy now accounts for **nearly 5% of national GDP**.</li> <li>Release of the <strong>India Bioeconomy Report (IBER) 2026</strong> and the <strong>BIRAC Impact Report</strong>, documenting commercialization, job creation and societal impact.</li> <li>Focus on nurturing talent from tier‑2 and tier‑3 cities, and promoting women entrepreneurs.</li> </ul> <h3>UPSC Relevance</h3> <p>The rapid expansion of the bioeconomy touches multiple UPSC syllabus areas: <strong>GS III – Economy</strong> (sectoral contribution to GDP, investment flows), <strong>GS I – Science &amp; Technology</strong> (biotech innovation